Applicant, as named in the Orange Book
Biogen Ma
Biogen Inc · Nasdaq: BIIB
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Next listed expiry: Qalsody on 1 Apr 2035. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Qalsody NDA 215887 tofersen | 1 Apr 2035 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.